Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Omega vs Epoetin Alfa in Dialysis Patients
NCT00322413Phase 3Completed
- Sponsor
- General Hospital Sveti Duh
- Start
- Jan 1997
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised trial of epoetin omega in anemia of chronic kidney disease (2 arms), sponsored by General Hospital Sveti Duh. Primary endpoint: Hemoglobin level at 12 weeks. Started Jan 1997; status: completed.
02
Drugs
epoetin omega
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00322413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322413.